Pier Capital, LLC Novo Cure LTD Transaction History

Pier Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$28.72 - $52.63 $2.44 Million - $4.48 Million	-85,074 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $5.69 Million - $9.32 Million	-177,787 Reduced 67.64%	85,074 $4.46 Million
Q2 2018 Aug 08, 2018	SELL	$19.85 - $32.0 $1.66 Million - $2.67 Million	-83,489 Reduced 24.11%	262,861 $8.23 Million
Q1 2018 May 14, 2018	SELL	$19.3 - $23.65 $756,116 - $926,536	-39,177 Reduced 10.16%	346,350 $7.55 Million
Q4 2017 Feb 15, 2018	BUY	$16.3 - $21.9 $1.83 Million - $2.46 Million	112,176 Added 41.04%	385,527 $7.79 Million
Q3 2017 Nov 13, 2017	BUY	$18.05 - $21.75 $4.93 Million - $5.95 Million	273,351	273,351 $5.43 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.15B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.